Dual-laser “808 and 1,064 nm” strategy that circumvents the Achilles’ heel of photothermal therapy
Proceedings of the National Academy of Sciences · 17.06.2025 · 122 (24)
DOI: 10.1073/pnas.2503574122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 09.06.2025. Verfasst von Qihang Ding und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Korea University, Seoul 02841, Korea. Hauptthemen laut MEDLINE: Photothermal Therapy, Breast Neoplasms. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Council of Korea, Robert A. Welch Foundation, China Scholarship Council (CSC).
Abstract (Originalsprache)
Breast cancer has now overtaken lung cancer as the “world’s leading cancer,” yet detecting and implementing effective therapies remains a significant challenge. Substantial advances have been made in photothermal therapy (PTT), where photosensitizers use photonic energy to induce localized hyperthermia for cancer eradication. This pioneering approach is gaining traction in clinical settings. However, traditional PTT faces inherent limitations, including the risk of damage to neighboring healthy tissues and potential inflammatory responses due to overheating. Drawing inspiration from the distinct characteristics of aggregation-induced emission the small molecule, PM331, was chosen for study. This donor–acceptor–donor system displays good photothermal conversion efficiencies (40% and 66%) upon excitation at 808 nm and 1,064 nm, respectively. It is also characterized by attractive optical features in the second near-infrared (NIR-II) window. Using nanoparticles containing PM331, PM331@F127 , we have developed a PTT strategy, termed dual-laser PTT (DLPTT), that involves successive excitation using 808 nm and 1,064 nm lasers guided by both NIR-II fluorescence and photoacoustic imaging. The DLPTT strategy involves two steps. First, it initiates DNA damage and downregulates heat shock protein expression as the result of an initial brief irradiation with an 808 nm laser. This is then followed by irradiation with a 1,064 nm laser to ablate tumor cells while minimizing inflammation and harm to surrounding healthy tissues. Based on the findings reported here, we suggest that DLPTT could represent an attractive approach to precision medicine and one that could make PTT more amenable to clinical implementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Korea University, Seoul 02841, Korea.
- Guangdong Key Laboratory of Nanomedicine, Chinese Academy of Sciences-Hong Kong Joint Lab for Biomaterials, Chinese Academy of Sciences Key Laboratory of Biomedical Imaging Science and System, Center for Nanomedicine an…
- State Key Laboratory of Flexible Electronics & Institute of Advanced Materials, Nanjing University of Posts & Telecommunications, Nanjing 210023, China.
- Department of Chemistry, The University of Texas at Austin, Austin, TX 78712-1224.
ORCID-Profile: Qihang Ding, Jungryun Kim, Hui Zhou, Jonathan L Sessler, Jong Seung Kim
Förderung
- National Research Council of Korea
- Robert A. Welch Foundation
- China Scholarship Council (CSC)
- National Key Development Research Council of China
- Shenzhen Basic Research
- | Shenzhen Technology Development Program
- Major Instrumentation Development Program of The Chinese Academy of Sciences
- National Science Foundation of Jiangsu Province
Zitieren
APA
Ding, Q., Liu, J., Wang, Y., Kim, J., Huang, Z., Lee, Y., Zhou, H., Zhang, P., Sessler, J. L., & Kim, J. S. (2025). Dual-laser “808 and 1,064 nm” strategy that circumvents the Achilles’ heel of photothermal therapy. Proceedings of the National Academy of Sciences, 122(24). https://doi.org/10.1073/pnas.2503574122
Vancouver
Ding Q, Liu J, Wang Y, Kim J, Huang Z, Lee Y, et al. Dual-laser “808 and 1,064 nm” strategy that circumvents the Achilles’ heel of photothermal therapy. Proceedings of the National Academy of Sciences. 2025;122(24). doi:10.1073/pnas.2503574122
BibTeX
@article{Ding2025,
author = {Ding, Qihang and Liu, Jiqiang and Wang, Yue and Kim, Jungryun and Huang, Zhihui and Lee, Yubin and Zhou, Hui and Zhang, Pengfei and Sessler, Jonathan L and Kim, Jong Seung},
title = {Dual-laser “808 and 1,064 nm” strategy that circumvents the Achilles’ heel of photothermal therapy},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {24},
doi = {10.1073/pnas.2503574122}
}
EUVIMED